Thoracic Oncology (Lung Cancer)

Lung Cancer Screening Program

The primary goal of low-dose computed tomography (LDCT) lung cancer screening is to detect lung cancer at curable stages while minimizing harm to those without lung cancer. Since 2015, Cleveland Clinic’s lung cancer screening program has performed > 35,000 LDCTs, with > 7,250 individuals screened in 2023. More than 450 lung cancers have been diagnosed through screening since the program began.

In 2023, our centralized program grew to a total of 19 sites.. Despite 9% of screening exams being category 4, fewer than 0.5% of those screened have had an invasive procedure performed for a benign finding. We continue to strive to provide the highest quality of care to those being screened while growing through adopting the expanded eligibility criteria of the United States Preventive Services Task Force (USPSTF) and increasing our outreach efforts.

Podcasts

Cleveland Clinic Respiratory Medicine hosts podcasts series available on all major platforms including Apple, Google, Soundcloud and Spotify; click on a link below to listen and learn more.

‘Should You Be Screened for Lung Cancer?’ and ‘Lung Cancer Screening: It’s More Than a CT Scan’ hosted by Raed Dweik, MD, MBA, Institute Chief and Chair, Pulmonary & Critical Care Medicine with guest Peter Mazzone, MD, MPH, Section Head, Thoracic Oncology and Program Director, Lung Cancer Screening at Cleveland Clinic.

'ATS 2024 Highlights' hosted by Kristine Highland, MD, MSCR, Vice Chair of Research in the Integrated Hospital-care Institute, with guests Peter Mazzone, MD, MPH, Section Head, Thoracic Oncology and Program Director, Lung Cancer Screening at Cleveland Clinic and Vickram Tejwani, MD.

The Percentage of Individuals Who Complete LDCT Screening for Lung Cancer Who are Screen-Eligible Based on the USPSTF Criteria

2022 - 2023

20222023
Baseline Exams

98.8

(N = 2617)

97.8

(N = 3744)

Annual Exams

99.5

(N = 2953)

96.3

(N = 3611)

LDCT = low-dose computed tomography, USPSTF = United States Preventive Services Task Force

Percentage of Individuals Who Currently Smoke Who Participated in LDCT Screening That Have Documentation of a Smoking Cessation Intervention¹

2022 - 2023

¹Based on percentage of individuals who currently smoke who participate in LDCT screening who have documentation of a smoking cessation intervention (e.g. discussion, an offer to participate in a smoking cessation program) during the shared decision-making visit.

LDCT = Low-dose computed tomography

Percentage of Lung Cancer LDCT Screen Eligible Individuals who Complete a LDCT Exam and are Identified to Have Lung-RADS® Category 1 or 2 Findings who Complete the Next Annual LDCT Screening Exam (2023 N = 4747)

2022 - 2023

LDCT = Low-dose computed tomography, Lung-RADS® = lung imaging reporting and data system

Percentage of Individuals who Complete a LDCT Lung Cancer Screening Exam and Were Identified to Have a Lung-RADS® Category 3 Nodule in Which a Surveillance LDCT Scan is Performed at 6 Months (+/- 2 months)

2022 - 2023

LDCT = Low-dose computed tomography, Lung-RADS® = lung imaging reporting and data system

Percentage of Individuals who Complete a LDCT Lung Cancer Screening Exam and Were Identified to Have a Lung-RADS® Category 4 (A) Nodule in Which a Surveillance LDCT Scan, CT Scan, or PET Scan is Performed at 3 Months (+/- 6 weeks)

2022 - 2023

CT = computerized tomography, LDCT = low-dose computed tomography, Lung-RADS® = lung imaging reporting and data system, PET = positron emission tomography

Time from Identification of a Lung-RADS® Category 4B or 4X Lung Nodule/Mass on a LDCT Screening Exam to the Diagnosis of Lung Cancer (N = 39)

2022 - 2023

LDCT = low-dose computed tomography, Lung-RADS® = lung imaging reporting and data system